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1. INTRODUCTION AND AIMS 
 
Fluorine-containing organic scaffolds are very rare in nature, but they have 
received significant interest in many different research fields. The replacement of 
hydrogen atom by fluorine or a fluorinated group could furnish biomolecules with unique 
features. The incorporation of fluorine in biomolecules can lead to remarkable changes in 
their physical, chemical and biological properties. There are already many drugs on the 
market, which contain at least one fluorine atom, and this number is expected to increase 
in years to come 
1–3
. 
Saturated N-heterocycles have increasing attention in pharmaceutical and organic 
chemistry. A large number of nitrogen-containing saturated cyclic amines have been used 
in clinics as antibiotics, analgesics, antidepressants, anticancer, anti-HIV and anti-HCV 
agents
4–6
. According to the medicinal chemistry literature, there are two main fields of 
interest with respect to the structures of the present drug candidates: the popularity of 
organofluorine scaffolds and the ubiquity of nitrogen heterocycles
7–12
. 
The synthesis of fluorine-containing molecular entities and fluorination are two 
main research topics in the Institute of Pharmaceutical Chemistry at the University of 
Szeged. The research is focused on the incorporation of fluorine into cyclic -amino acids 
and cycloalkene derivatives with diverse functionalities. Two different synthetic 
approaches have been applied to furnish a molecule with fluorine. Direct fluorination 
means a late-stage exchange by using fluorinating reagents (Figure 1)
2,13–24
. 
Figure 1. Examples of the fluorination of β-amino acid derivatives 
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On the other hand, application of fluorinated compounds like fluorine-containing 
amines could offer a way for the access of fluorine-containing N-heterocycles. 
Due to the high biorelevance of organofluorine scaffolds and the importance of N-
heterocyclic compounds, our aim was to develop a novel and efficient stereocontrolled 
procedure for the access of new fluorine-containing saturated N-heterocycles. The 
introduction of a fluorine atom into the structure of a molecule started with the 
dihydroxylation of the olefinic bond of various cycloalkane β-amino acids or β-lactams, 
followed by NaIO4-mediated ring cleavage of the diol intermediate and ring expansion 
with reductive amination, resulting in novel fluorine-containing N-heterocycles (Figure 2). 
 
Figure 2. Synthetic processes explored in the present PhD work  
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2. LITERATURE BACKGROUND 
2.1. Importance of fluorination and fluorinated saturated N-
heterocycles 
 
Fluorinated molecules are very uncommon in nature. Fluorine has rather unique 
properties and the incorporation of fluorine into the structure of an organic molecule can 
generate unique changes, which cannot be attained by the use of any other element
2,3
. It 
has great interest because a large number of fluorine-containing structures are widely 
applied in different areas like material sciences or medicinal and pharmaceutical chemistry 
as well as agrochemistry
25–28
. The size of a fluorine atom is very similar to that of 
hydrogen and fluorine has the highest electronegativity in the periodic table. This could 
lead to increasing lipophilicity and stability, and could furnish resistance to metabolic 
transformations. The van der Waals radius of fluorine is more similar to that of oxygen 
and the carbon–fluorine bond length is comparable but weaker than the carbon–oxygen 
bond. Hydrogen-bonding interactions could give special characteristics to the structure 
with at least one fluorine atom. Due to these unique properties, it is a routine in drug 
design to furnish a biomolecule with fluorine or fluorinated groups. There are an 
increasing number of drugs on the market, which contain at least one fluorine atom 
(Figure 3)
1,2,29–32
. 
Figure 3. Important representatives of fluorine-containing market leader drugs 
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 Saturated N-heterocycles are very prominent building blocks in synthetic bioactive 
products and medicinal compounds. Five-, six-, and seven-membered rings are the most 
common structural units. They are increasingly attractive scaffolds in the production of 
new drugs. Scientists prefer to use saturated building blocks, especially saturated N-
heterocycles in the development of new pharmaceuticals
4,6
. Figure 4 shows some 
representative N-heterocyclic structures with biological relevance
33–37
. 
 
Figure 4: Some N-heterocyclic compounds with biological relevance 
 
Among organofluorine compounds of high biorelevance, saturated N-heterocyclic 
scaffolds with fluorine has a special interest. Not surprisingly, the changing of an 
azaheterocycle motif into a fluorine-containing one may improve the metabolic stability or 
reduce basicity, thereby providing better bioavailability to a certain molecule. Fluorinated 
piperidines and their derivatives have shown promising biological activity because of the 
increased lipophilicity. β-Fluoramine and trifluoroamine moieties are also present in 
various fluorine-containing derivatives with biological importance (Figure 5)
7,9,10
. 
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Figure 5. Some biologically important fluorine-containing N-heterocyclic derivatives 
 
There has been a great interest in fluorine-containing pyrrolidines or piperidines in 
medicinal chemistry, which are present in various drugs
38
. Although fluorinated azepanes 
are much less mentioned in the literature, they may receive wide attention in 
pharmaceutical design in the future
9,39
. It is well-known that fluorine-containing 
tetrahydroisoquinoline derivatives, N-bridged bicyclic scaffolds, and other N-
fluoroalkylated molecular entities have great biological relevance
40–42
. 
 
2.2 . Synthesis of saturated N-heterocycles from dialdehyde 
compounds 
 
A large number of synthetic pathways have been developed to obtain 
azaheterocycles including aziridines, azetidines, pyrrolidines, piperidines or azepanes
43–47
. 
In organic and pharmaceutical chemistry the creation of novel N-heterocycles is a well-
explored area. However, due to the increasing interest of these scaffolds, the development 
of new and efficient protocols for N-heterocycles is an enduring challenge in modern 
chemistry
6
. 
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2.2.1. Oxidative ring opening 
 
The oxidative ring cleavage of olefinic compounds is a widely applied important 
transformation in organic chemistry to achieve the corresponding carbonyl compounds 
(aldehydes, ketones or acids). Two main methodologies are known in the literature for 
oxidative ring opening: either through ozonolysis of alkenes
 
or cleavage of vicinal diols
48-
56
. Both are useful methods to prepare carbonyl compounds, which have great interest. A 
standard pathway to access oxidative ring opening directly is ozonolysis of olefins, 
illustrated in Scheme 1
51
. 
 
Scheme 1. Olefinic bond cleavage by ozonolysis 
 
An alternative pathway involves the oxidation of the olefinic bond resulting in 1,2-
diols, which is followed by cleavage with NaIO4 or other oxidizing agents. The dialdehyde 
produced by the reaction of a cis-diol may react further to higher oxidation products. OsO4 
is a commonly used, reliable and widely applied reagent for the oxidation of alkenes into 
vicinal diol compounds. Since it is toxic and expensive, a catalytic amount is used in the 
presence of some oxidizing agent
54
. Milas and co-workers were the first to show that the 
oxidation of alkenes could be catalyzed with osmium tetroxide with the use of hydrogen 
peroxide
52
. The latter was replaced by some other oxidizing agents like tert-butyl 
hydroperoxide, oxygen, sodium hypochlorite, and amine N-oxides
53
. Amine N-oxides, 
such as N-methylmorpholine N-oxide (NMO), as co-oxidants are able to reoxidize the 
Os(VI) intermediate species to an Os(VIII) species. Thanks to this property, it is 
satisfactory to use only a catalytic amount of OsO4 (Figure 6). The cis hydroxylation of 
olefins with NMO provided better yields than hydrogen peroxide or metal chloride 
reagents
53
. 
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Figure 6. Mechanism of dihydroxylation with NMO/OsO4 
 
Upjohn and co-workers applied a two-step procedure for the cleavage of the 
olefinic bond. First OsO4/NMO produced the vicinal diol intermediate, which underwent 
further oxidation by the treatment of sodium periodate (NaIO4) giving carbonyl 
compounds (Scheme 2)
51,54
. 
 
Scheme 2. Upjohn dihydroxylation and diol cleavage 
 
This procedure was improved with the use of oxone with OsO4 (Borhan and co-
workers)
48
 or m-CPBA, HBF4 and ArI (Ochiai et al.)
55
. However, these processes have 
limitations because under the strong conditions used both lead to carboxylic acids. 
Phenyliododiacetate [PhI(OAc)2] is an efficient and selective reagent to cleave 1,2-diol 
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derivatives providing aldehydes and ketones. This protocol could offer a practical one-pot 
synthetic method as summarized in Scheme 3
51
. 
 
Scheme 3. One-pot cleavage of vicinal diols by PhI(OAc)2 
 
Functionalized dialdehydes are important substrates, which could be transformed 
into various substituted alicyclic, heterocyclic or polysubstituted products. The synthetic 
approaches described above provide an opportunity for the ring opening of several 
cycloalkene derivatives with C–C double bond in the ring, resulting in diformyl 
compounds. Nicolaou and co-workers applied the ring-opening method for several cyclic 
1,2-diol derivatives by PhI(OAc)2 in good yields. Scheme 4 shows a representative 
example of their ring-cleavage protocol
51
. 
 
Scheme 4. Synthesis of a linear dialdehyde by oxidative ring cleavage 
 
 Fricke et al. reported the synthesis of iminodiacetaldehyde derivatives from the 
corresponding 3,4-dihydroxypyrrolidines. The transformation was based on 
dihydroxylation followed by an oxidative ring cleavage reaction by the treatment of 
lead(IV) acetate [Pb(OAc)4] or sodium periodate in aqueous solution (Scheme 5)
56
. The 
products formed represent promising building blocks, as pharmacologically active agents, 
especially N-heterocyclic diols
56
. 
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Scheme 5. Synthesis of iminodiacetaldehyde 26 
 
This oxidation cascade, which involves a dihydroxylation step and oxidative ring 
cleavage, resulting in aldehydes, ketones, acids or dialdehydes, could supply promising 
intermediates for the synthesis of pharmacologically valuable scaffolds. 
 
2.2.2. Reductive amination 
 
Since amines represent a large and important class of pharmaceuticals and 
agrochemicals, the preparation of C–N bonds has a great interest in organic chemistry. 
There are several methodologies, but reductive amination is the most impressive pathway 
for the fabrication of a carbon–nitrogen bond in chemical industry57. This method, also 
called reductive alkylation, involves the condensation reaction of a carbonyl compound 
(aldehydes, ketones) with ammonia, primary or secondary amines in the presence of a 
reducing agent
58,59
. The first step of the reaction provides a carbinolamine by the 
condensation of a carbonyl compound and an amine. This intermediate undergoes 
reversible dehydration to an iminium ion, what is reduced to the amine through an 
irreversible hydride addition. The pathway is illustrated in Scheme 6
58
. 
 
Scheme 6. The reaction mechanism of reductive alkylation/amination 
 
11 
 
 
There are two different ways to carry out reductive alkylations. In indirect 
reductive aminations, the intermediate imines are isolated, and then they undergo 
reduction in the second step to achieve the corresponding amines. A one-pot reaction is 
also known, where the imines are not separated; nevertheless, a reducing agent is added 
and the reaction leads to the required amine compounds. This direct path is preferable as 
far as efficiency is concerned since it offers an easy access to the amines, which are 
important products or building blocks (Scheme 7)
59,60
. 
 
Scheme 7. Pathway of the direct (one pot) reductive amination 
 
Reductive amination of the carbonyl compounds is traditionally carried out with 
the use of a stoichiometric amount of reducing reagent. The commonly used agents for the 
reduction of carbon–nitrogen double bonds are metal hydrides like NaBH4, NaBH3CN or 
LiAlH4, molecular hydrogen, formates, silanes
57,59
. Sodium cyanoborohydride is a widely-
used popular reagent to reduce imines. Due to the electron-withdrawing effect of the 
cyanide substituent, it can provide mild conditions for the reduction. According to Borch 
and co-workers, the optimal pH for the reduction is between 5 and 7, and a wide range of 
solvents could serve as a soluble hydride source
58,61
. The introduction of a nitrogen atom 
into an alkyl group has great potential in the synthesis of N-containing heterocycles or 
building blocks in pharmaceutical chemistry. 
 
2.2.3. Transformation of linear dialdehydes into N-heterocycles 
 
Linear dialdehydes such as succinaldehyde or glutaraldehyde are promising 
substrates for a number of transformations like aldol, Mannich, Michael and Henry 
reactions. These dialdehydes are often used for the rapid synthesis of important skeletons 
with medium-sized carbo- and hetero-cyclic ring systems
62
. 
In 1917 Sir Robinson applied a novel thinking in his synthetic method and 
produced tropinone 39 in a one-pot reaction, using succinaldehyde 36, amine 37 and 
acetone dicarboxylic acid 38, presented in Scheme 8
62,63
. 
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Scheme 8. Total synthesis of tropinone from succinaldehyde 
 
Xu and co-workers reported a diastereo- and enantioselective synthetic method by 
the application of glutaraldehyde 40 to produce N-heterocycles like tetrahydropyridines 
using amine catalysis. A Mannich-type reaction was developed, which involved 41 formed 
in intramolecular aqueous cyclization of glutaraldehyde, N-PMP aldimine 42 and proline 
43 resulting in the corresponding tetrahydropyridine product 44 (Scheme 9)
64
. 
 
Scheme 9. Organocatalytic transformation of glutaraldehyde giving optically active 
tetrahydropyridines 
 
 Kumar et al. developed an extension of the above-described procedure. 
Cycloaddition of glutaraldehyde 40 gave asymmetric 2,3-disubstituted piperidine scaffold 
45 with reduction in the last step (Scheme 10)
65
. 
 
Scheme 10. Cycloaddition for piperidine synthesis 
 
 Chen and co-workers published a synthetic method for the synthesis of 
azaheterocycles starting with aliphatic dialdehyde. The key steps of the synthetic path are 
13 
 
 
an inverse electron demand aza-Diels–Alder reaction (ADAR) followed by an 
intramolecular hemiketal formation–oxidation reaction of the widely available N-Tos-1-
aza-1,3-butadiene 46 and linear dialdehydes (for example glutaraldehyde 40). This multi-
step process results in lactone[2,3-b]piperidine derivative 50 (Scheme 11)
66
. 
 
Scheme 11. Synthesis of a lactone[2,3-b]piperidine derivative via ADAR 
 
2.2.4. Transformation of dialdehyde derivatives across reductive 
amination 
 
A number of research groups have published methods for the synthesis of N-
heterocycles by the application of ring closing of linear dialdehydes under reductive 
amination
34,35,67–76
. 
Bols and co-workers developed a novel method for the access of isofagomine 8 and 
substituted hydroxypiperidines. The synthetic route started from epoxide 51, which is 
easily accessible from starch. After a two-step transformation, the resulting hemiacetal 52 
was submitted to reductive amination by using benzylamine. In the next step, periodate 
cleavage reaction gave enamine 54. The reduction of 54 afforded trans isomer 55 in 78% 
yield (Scheme 12)
34
. 
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Scheme 12. Synthesis of substituted hydroxypiperidines 
 
Chrick and co-workers developed a novel synthetic method for the access of 
polyhydroxylated N-alkoxypiperidines, which was based on ring closing of 1,5-
dialdehydes by double-reductive amination. The oxidative ring opening of olefin 56 was 
carried out by the classical method with OsO4/NaIO4 in dioxane and water resulting in 
cyclic hydrate 57 in diastereomeric forms. In the next step, double-reductive amination 
using benzylamine similar to the method developed by Bols gave the desired piperidine 
derivative 58 in a 71% isolated yield. This reaction was extended by using alkoxyamines. 
Thus, O-benzylhydroxylamine was applied for the above-described double-reductive 
amination affording N-alkoxypiperidine 59 in 46% yield. Upon further optimization, the 
highest yield of 59 was 81% using 2.5 equiv. of alkoxyamine (Scheme 13)
67
. After the 
optimization of the above method, they focused on the synthesis of more promising 
dialdehydes to achieve trisubstituted N-alkoxypiperidine analogs of isofagomine
67
. 
Scheme 13. Preparation of N-alkoxypiperidines with double-reductive amination 
15 
 
 
 
 In another study, the synthesis of carbohydrate-derived morpholine amino acids via 
oxidative cleavage and reductive amination was reported by Grotenberg et al. The 
synthetic route started from commercially available D-ribose 61, and the key steps of the 
pathway were glycol cleavage of 1,2-diol 63 (derived from protected SAA 62) with 
periodic acid followed by a double-reductive amination of the resulting dialdehyde 64 
giving substituted MAA derivatives 66a and 66b
68
. 
 
Scheme 14. An example of the synthesis of carbohydrate-derived MAAs 
 
 They performed the reductive amination directly with different amines including 
benzylamine at pH 5 (acidified with AcOH) in the presence of NaBH3CN as reducing 
agent. After purification, both diastereomeric morpholines were isolated with 22% yield 
(Scheme 14)
68
. 
The method, based on oxidative ring cleavage and reductive ring closure, is crucial 
in the synthesis of morpholine oligomers. The thymine morpholino monomer was 
prepared from 5’-O-dimethoxytrityl ribothymidine 67, which was submitted to oxidative 
ring cleavage mediated by sodium periodate followed by reductive amination with 
ammonium diborate. The dihydroxythymine morpholino monomer intermediate was 
16 
 
 
reduced with NaBH3CN providing the desired product 68 (Scheme 15)
69,70
. The product 
formed is the key monomer in the design of Eteplirsen (Exondys 51
TM
)
77,78
. 
 
Scheme 15 Synthesis of thymine morpholino monomer 68 
 
Azasugars (polyhydroxylated piperidines) possess high bioactivity. Shih et al. 
reported a synthetic path to achieve new trihydroxypiperidine derivatives from D-(-)-quinic 
acid in eleven steps starting with enone 69 prepared from D-(-)-quinic acid via a four-step 
transformation. The main steps of the procedure are oxidative ring opening of the olefinic 
bond, intramolecular reductive cyclization and deprotection by Pd/C-HCl to provide the 
required trihydroxy piperidine product 75 (Scheme 16)
71
. 
 
Scheme 16. Synthesis of trihydroxy piperidine scaffold 75 
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The preparation of piperidine derivatives is well-known in the literature, though 
methods to synthesize azepane compounds are less reported. Lin and co-workers 
developed a novel transformation for the synthesis of tri- and tetrahydroxyazepanes. These 
hydroxyazepanes are promising glycosidase inhibitors like their five- or six-membered 
analogs. The reported strategy is based on an oxidative cleavage reaction and subsequent 
reductive cyclization. The first step was the dihydroxylation of protected 1,4,5-cyclohex-
2-ene-triols, which were derived from D-(-)-quinic acid by the treatment of 
RuCl3/NaIO4/phosphate puffer (pH 7). The resulting vicinal diols were further reacted via 
NaIO4-mediated oxidative ring opening to achieve the corresponding diformyl 
compounds. The reductive cyclization was carried out with benzylamine in the presence of 
NaBH(OAc)3 as reducing agent (Scheme 17)
72
. 
 
Scheme 17. Synthesis of trihydroxyazepanes 
 
The above-described method was extended and further optimized for the synthesis 
of 7-hydroxymethyl-3,4,5-trihydroxyazepane. A different route starting from a protected 
cyclohexenetriol was defined, that includes only three steps: ozonolysis, reductive 
amination and deprotection (Scheme 18)
72,73
. 
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Scheme 18. Synthesis of 7-hydroxymethyl-3,4,5-trihydroxyazepane 
 
The research group of the Institute of Pharmaceutical Chemistry at the University 
of Szeged has published a novel, stereocontrolled synthesis of tashiromine and 
epitashiromine alkaloids. Indolizidine alkaloids are very important in medicinal chemistry, 
because they can exhibit a wide range of therapeutic activities such as anticancer, 
antimetastatic or antitumor effects. The strategy for the synthesis of tashiromine and 
epitashiromine alkaloids started from bicyclic β-lactam (±)-93. The procedure was based 
on the ring opening of the azetidinone skeleton followed by the ring cleavage of the C–C 
double bond of cyclooctene derivative (±)-95. The resulting crude dialdehyde (±)-97 was 
subjected to catalytic hydrogenolysis and after N-deprotection a reduction via double 
cyclization gave the desired product (±)-99 (Scheme 19)35. 
19 
 
 
Scheme 19. Synthesis of tashiromine (±)-99 
 
 The same method was applied for the synthesis of epitashiromine. The main 
difference is the epimerization of cis-β-aminocyclohexenecarboxylate (±)-95 giving C-1 
epimer trans amino ester (±)-100. Since the (±)-101 1:1 diastereoisomer mixture formed in 
OsO4/NMO dihydroxylation could not be isolated, it was further used in the ring-opening 
oxidation and reductive cyclization steps. After the reduction of the ester with LAH, 
epitashiromine (±)-104 could be isolated with 53% yield (Scheme 20)35. 
20 
 
 
 
Scheme 20. Synthesis of epitashiromine (±)-104 
 
 An efficient stereocontrolled preparation was described for the introduction of a 
nitrogen atom into a cyclic β-amino acid. The synthesis started from readily available 
unsaturated bicyclic β-lactams (±)-105, (±)-110 and (±)-113. Key steps of the 
stereocontrolled synthetic path are the oxidative cleavage of the ring C–C double bond and 
subsequent reductive amination with benzylamine. This method was applied for the 
synthesis of both racemic and enantiomerically pure forms
74–76
. 
 The preparation of piperidine-4-carboxylate enantiomers started from 
enantiomerically pure β-lactam (-)-105, which was submitted to dihydroxylation mediated 
by KMnO4. The further reaction path was based on oxidative ring opening of the vicinal 
diol mediated by NaIO4 followed by ring expansion giving novel β-amino acid scaffolds in 
enantiomerically pure form (Scheme 21)
74
. 
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Scheme 21. Enantioselective synthesis of piperidine-4-carboxylates 
 
The same transformations were applied for the regio- and stereoisomeric synthesis 
of azepane amino esters (Figure 7)
75
 . 
Figure 7. Pathway for the access of regio- and stereoisomeric azepane amino esters 
 
Azabicyclic β-amino esters were obtained from exo-norbornene β-lactam with the 
above-described ring-opening/ring-closing method. Racemic diendo norbornane amino 
ester 116 as starting material provided products 118 and 119 in a ratio of 9:1. The possible 
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explanation is the keto–enol tautomerism of the diformyl derivatives, which yielded a 
mixture of diendo and diexo heterocyclic amino esters (Scheme 22)
76
. 
 
Scheme 22. Synthesis of azabicyclic β-amino esters 
 
The synthetic pathway described above was applied for the transformation of 
diexo-N-Boc-protected norbornene β-amino ester 120. The oxidative ring-opening and 
reductive ring-closure procedure afforded the desired azabicyclic β-amino ester 119 
(Figure 8)
76
. 
 
Figure 8. Synthesis of diexo azabicyclic β-amino ester 
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3. RESULTS AND DISCUSSION 
 
Taking into consideration the appropriate biorelevance of saturated N-heterocycles 
and organofluorine scaffolds, our aim was to combine these molecular structures. The 
actual work was based on the oxidative ring opening of various substituted cycloalkenes 
and unsaturated cyclic β-amino acid scaffolds. It was followed by cyclization of the 
diformyl intermediates under reductive amination condition in order to synthesize various 
N-heterocyclic motifs incorporating fluorinated entities. The stereocontrolled synthetic 
concept included the use of commercially available fluorine-containing amines to achieve 
novel fluorine-containing piperidine and azepane derivatives and 1,2,3,4-
tetrahydroisoquinoline compounds. 
 
3.1. Synthesis of starting materials 
 
First, our aim was the preparation of five-membered substituted cycloalkenes, 
namely, a cyclopentene carboxylate and a cyclopenteneamine. Cyclopentenecarboxylic 
acid benzyl ester 122 was prepared from commercially available cyclopent-3-
enecarboxylic acid 121 with benzyl chloride and DBU in THF under reflux. Next, the ester 
substituent of the cyclopentene ring was changed to a protected amine. Unsaturated acid 
121 was converted under Curtius reaction conditions to Cbz-protected amine derivative 
124. The Curtius rearrangement was performed via a known pathway in dry toluene with 
TEA and diphenylphosphoryl azide (DPPA) in the solution of benzyl alcohol with an 
overnight reflux. This reaction was also applied for the synthesis of protected 
cyclohexeneamine (±)-125 from commercially available cyclohex-3-enecarboxylic acid 
(±)-12379. The preparation of five- and six-membered substituted cycloalkenes is 
presented in Scheme 23. 
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Scheme 23. Preparation of five- and six-membered substituted cycloalkenes 
 
Next, a method described previously was applied for the preparation of unsaturated 
bicyclic β-lactams (±)-127 and (±)-130a,b as starting materials. Cyclopentadiene 126 and 
cyclohexadienes 129a,b were submitted to [2+2] cycloaddition with N-chlorosulfonyl 
isocyanate (CSI) giving the required sulfonamide. Then unsaturated bicyclic β-lactams 
were obtained by the hydrolysis of the SO2Cl group with Na2SO3
80
. The desired products 
were recrystallized from diisopropyl ether and further used for lactam ring opening at 0 °C 
in dry EtOH with HCl/EtOH. The ester hydrochlorides were crystallized with diethyl ether 
and filtered. This step was followed by N-protection with Cbz-Cl and benzoyl chloride. In 
details, Et3N was added to a solution of amino ester hydrochloride in THF at 0 °C 
followed by the addition of Cbz-Cl and stirring the mixture for 10 h at room temperature 
(Scheme 24)
35
. Benzoyl protection was carried out with benzoyl chloride at 0 °C in 
toluene, in the presence of NaHCO3 in a 1-h reaction
81
. In both reactions the crude 
products were purified by column chromatography on silica gel (n-hexane/EtOAc) 
affording Cbz- and COPh-protected β-amino esters (Scheme 24). 
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Scheme 24. Synthesis of N-protected β-aminocyclopentene and β-aminocyclohexene 
carboxylates 
 
 Epimerization at C-1 was also executed with NaOEt in EtOH with the involvement 
of the active methine group of cis N-protected amino esters (±)-128a,b and (±)-131a,b. 
The crude materials were purified by column chromatography on silica gel (n-
hexane/EtOAc) to give trans isomers (±)-132a,b and (±)-133a,b (Scheme 25)74. 
 
Scheme 25. Epimerization of cis N-protected amino esters 
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3.2. Synthesis of fluorine-containing functionalized piperidine 
derivatives 
 
The synthetic concept included the preparation of fluorine-containing amines and 
was based on the oxidative ring cleavage of the above-described unsaturated starting 
materials and some readily available cycloalkenes, followed by ring closure via reductive 
amination and ring expansion of the diformyl intermediates. 
Synthesis of monosubstituted fluorine-containing piperidines 
Cyclopentenecarboxylic acid benzyl ester 122 was transformed to the 
corresponding dialdehyde. First, 122 was oxidized with NMO/OsO4 providing 1,2-cis-diol 
derivative (±)-134 as a mixture of stereoisomers in nearly 1:1 ratio. In general, 
dihydroxylation of substituted cycloalkenes was accomplished using NMO and a catalytic 
amount of OsO4 (2%) in t-BuOH solution. Both reagents were added to the stirred solution 
of substituted cycloalkenes in acetone, and the mixture was stirred further for 3 h at room 
temperature. After completion of the reaction, the mixture was treated with saturated 
aqueous Na2SO3 solution and then extracted with CH2Cl2. The crude product was purified 
by means of column chromatography on silica gel (n-hexane/EtOAc). The resulting 
mixture of stereoisomers could not be separated either by chromatography or by 
crystallization. However, in the next oxidative ring-cleavage step, the stereocenters 
disappear and, consequently, the mixture of diastereoisomers could be used further 
without any problem. The NaIO4-mediated oxidation of this mixture provided the 
corresponding unstable linear dialdehyde 135, which was immediately submitted to 
reductive amination without isolation or purification. The oxidative ring cleavage step was 
carried out with NaIO4 in THF/H2O under Ar atmosphere. After stirring for 1 h at 20 °C, 
H2O was added until the precipitate dissolved. The mixture was then extracted with 
CH2Cl2 and after solvent evaporation, the dialdehyde product was used in the next step 
without isolation. Reductive ring closing was performed with commercially available 
fluorine-containing amine 2,2,2-trifluoroethylamine hydrochloride. 
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Scheme 26. Synthesis of fluorine-containing piperidine derivative 141 from cyclopentene 
carboxylate via a diformyl intermediate 
 
Reductive ring expansion was carried out between diformyl intermediate 135 and 
the above-mentioned fluorine-containing amine, followed by treatment with NaBH3CN in 
the presence of NaHCO3 and AcOH in EtOH, resulting in the corresponding 
trifluoromethylated piperidine derivative 141 (Scheme 26). After a 3-h reaction, the 
mixture was diluted with H2O and extracted with CH2Cl2. The residue was purified by 
column chromatography on silica gel (n-hexane/EtOAc). A general mechanism of the 
double-reductive amination is also presented in Scheme 26. 
Reductive amination of dialdehydes could be applied by using other fluorine-
containing building blocks to achieve other fluorinated piperidines. For this purpose, 
diformyl derivative 135 was treated with commercially available 2-fluoroethylamine 
hydrochloride or 2,2-difluoromethylamine hydrochloride followed by reduction yielding, 
respectively, the corresponding mono- or difluorinated piperidine derivative (±)-142 and 
(±)-143 (Scheme 27). 
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Scheme 27. Synthesis of fluorine-containing piperidine derivatives 
 
 Next, Cbz-protected amine 124 (synthesized from commercially available 
cyclopent-3-enecarboxylic acid 121 with Curtius rearrangement) underwent 
dihydroxylation furnishing a 1:1 mixture of vicinal diol derivative (±)-144, presented in 
Scheme 28. 
 
Scheme 28. Synthesis of functionalized piperidine derivative 146 
 
Again, this mixture was used in the next step without separation of the 
diastereomers of (±)-144 to give dialdehyde 145. This diformyl intermediate was further 
used without isolation via double-reductive amination with 2,2,2-trifluoroethylamine in 
the presence of NaBH3CN affording trifluoromethylated piperidine 146 with 64% yield 
(Scheme 28). 
Synthesis of fluorine-containing piperidine β-amino esters 
Due to their appreciated biological potential, N-heterocyclic β-amino acids are 
important motifs in pharmaceutical and organic chemistry. A series of fluorine-containing 
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acyclic α- and β-amino acids exhibit antitumoral or antibiotic properties43,82–84. 
Biomolecules containing β-fluorinated or β-trifluorinated amine units are remarkable 
scaffolds in medicinal chemistry or agrochemistry
3,11,32,85,86
. Thus, fluorine-containing 
pyrrolidines and piperidines, which are present in drugs, have great interest in medicinal 
chemistry
7,38,87–89
. Thanks to these facts, our next goal was to apply the ring-opening/ring-
closing protocol to synthesize unsaturated β-amino acid derivatives. 
Accordingly, unsaturated β-amino esters (±)-128a,b were transformed to 
dihydroxylated cis amino esters (±)-147a,b using NMO/OsO4-mediated dihydroxylation. 
These were then treated with NaIO4 in THF/H2O to form the corresponding unstable open-
chain dialdehyde amino esters (±)-148a,b74 and then reacted further without isolation.  
Reductive amination was carried out upon treatment with commercially available 2,2,2-
trifluoroethylamine hydrochloride with NaBH3CN as reducing agent in the presence of 
NaHCO3 in EtOH. Substituents of the resulting (±)-149a,b cis β-amino esters are attached 
to the C-3 and C-4 atoms of the piperidine framework (Scheme 29). 
The configuration of the chiral centers in (±)-149a,b is predetermined by the 
structure of the starting materials since the stereocenters at C-1 and C-2 of amino esters 
(±)-128a,b were not affected during the ring expansion procedure. Consequently, the cis 
amino ester afforded the corresponding piperidine derivative with the carboxylate and 
carbamate/amide functions in a cis relative arrangement.  
Analogously, dihydroxylated amino esters (±)-150a,b with the ester and the N-
protected group in a trans relationship were submitted to NaIO4-mediated oxidative ring 
opening. The ring-closing procedure of the formed unstable diformyl intermediates (±)-
151a,b with trifluoroethylamine and NaBH3CN afforded trans trifluoromethylated 
piperdine amino esters (±)-152a,b (Scheme 29). Amino esters (±)-152a,b could be 
accessed on an alternative pathway by epimerization at C-4 of (±)-149a,b with NaOEt in 
EtOH with the involvement of the active methine group
74,90–92
. 
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Scheme 29. Synthesis of trifluoromethylated piperdine β-amino ester frameworks 
 
By the variation of the fluorine-containing building element, the synthetic concept 
could be readily extended to access novel fluorine-containing N-heterocyclic β-amino acid 
derivatives. A demonstrative example consists of the reductive amination either with 2-
fluoroethylmine hydrochloride or 2,2-difluoroethylamine hydrochloride. Thus, dialdehyde 
(±)-148b was submitted to reductive ring expansion on treatment with these commercially 
available fluoroamines in the presence of NaHCO3 and NaBH3CN, yielding the 
corresponding monofluorinated and difluorinated piperidine β-amino esters (±)-153 and 
(±)-154 (Scheme 30). 
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Scheme 30. Synthesis of monofluorinated and difluorinated piperidine β-amino esters (±)-
153 and (±)-154 
 
A convenient and efficient stereocontrolled procedure has been demonstrated for 
the access of different types of fluorinated N-heterocycles with piperidine skeleton. The 
developed procedure is generally applicable and the synthetic path includes an oxidative 
ring cleavage and a double-reductive amination to achieve substituted piperidine scaffolds 
with varied substitution patterns. 
 
3.3. Synthesis of fluorine-containing functionalized azepane 
derivatives 
 
The transformation of dialdehyde substrates could also be applied for the synthesis 
of seven-membered functionalized N-heterocyclic systems. Fluorine-containing azepane 
motifs are relatively less frequently reported in the literature. However, because of the 
important role of various functionalized counterparts in pharmaceutical design, they may 
receive increasing attention in the future
9,39
. 
 Synthesis of monosubstituted fluorine-containing azepane derivatives 
Due to the rising interest of azepane structures, our next aim was the extension of 
the above-described synthetic technique to the preparation of trifluoromethylated azepane 
derivatives. For this purpose, we selected the six-membered analogs of the 
aminocyclopentene ester investigated above. Ethyl cyclohex-3-enecarboxylate (±)-155, 
available on the market, was first submitted to dihydroxylation to form (±)-156 as a 
mixture of diol diastereoisomers in a ratio 1:1. Similar to the five-membered analogs, this 
dihydroxylated diastereoisomer mixture could not be separated and, consequently, it was 
used further in the next step. Thus, ring opening with NaIO4 afforded the corresponding 
open-chain dialdehyde (±)-157, which was next transformed without isolation on 
treatment with trifluorinated ethylamine into azepane derivative (±)-158 (Scheme 31). 
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Scheme 31. Synthesis of functionalized azepane derivative (±)-158 
 
The synthesis of a Cbz-protected amine-substituted fluorinated azepane could be 
achieved by starting from cyclohexeneamine (±)-125 synthesized by the Curtius reaction. 
Dihydroxylation of (±)-125 led to diol mixture (±)-159, which was transformed by 
oxidative ring cleavage in the presence of NaIO4. Again, the unstable diformyl 
intermediate (±)-160 was further used without isolation. The ring closure was carried out 
by treatment with 2,2,2-trifluroethylamine hydrochloride in EtOH, in the presence of 
NaHCO3 and NaBH3CN. The process involved reductive amination and resulted in 
substituted azepane derivative (±)-161 containing the desired trifluoromethyl group 
(Scheme 32). Note that the formation of the seven-membered ring system provides lower 
yield in comparison with those of the six-membered analogs. 
Scheme 32. Synthesis of functionalized azepane derivative (±)-161 
 
Synthesis of disubstituted trifluoromethylated azepane derivative 
In continuation, our next goal was to synthesize disubstituted trifluoromethylated 
N-heterocyclic derivatives. For this purpose, the olefin bond of commercially available 
cyclohexene cis-diester 162 was transformed with OsO4/NMO to vicinal diol 163. Then 
NaIO4-mediated oxidative ring opening of 163 followed by reductive ring expansion with 
trifluoroethylamine provided azepane diester 165 via the corresponding dialdehyde motif 
164 (Scheme 33). 
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Scheme 33. Synthesis of functionalized azepane derivative 165 
 
The configuration of the chiral centers in 165 is predetermined by the structure of 
starting material 162 since the stereocenters were not affected during the ring-expansion 
procedure. 
 Synthesis of fluorine-containing azepane β-amino esters 
The synthetic approach discussed above was then applied for the stereocontrolled 
synthesis of trifluoromethylated azepane β-aminocarboxylates. First, cis- and trans-2-
aminocyclohex-4-enecarboxylates (±)-131a and (±)-133a (derived from bicyclic β-lactam) 
were oxidized with NMO/OsO4 affording the corresponding vicinal diol derivatives (±)-
166a and (±)-168a. In the next step, these dihydroxylated esters were transformed into cis 
and trans amino esters (±)-167a and (±)-169a bearing an azepane ring. The reaction steps 
are oxidative ring cleavage and stereocontrolled ring enlargement through reductive 
amination with 2,2,2-trifluoroethylamine hydrochloride and NaBH3CN. In the 
trifluoromethylated azepane products, the ring nitrogen atom is in a distance of three 
carbon atoms from the carbamate group (Scheme 34). 
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Scheme 34. Synthesis of trifluormethyl-containing azepane β-amino acid stereoisomers 
 
Our next aim was the preparation of the regioisomers of trifluoromethylated 
azepane derivatives (±)-167a, (±)-169a starting from bicyclic β-lactam (±)-130b, the 
regioisomer of (±)-130a. Lactam (±)-130b was converted through lactam ring opening by 
ethanolysis followed by N-Cbz protection yielding (±)-131b, which was then subjected to 
epimerization to give derivative (±)-133b (see Schemes 24 and 25). The C–C double bond 
dihydroxylation of these two compounds with NMO and OsO4 provided vicinal diols (±)-
166b and (±)-168b. In the next step, both dihydroxylated β-amino ester stereoisomers 
were subjected to oxidative ring opening mediated by NaIO4 followed by reductive ring 
expansion with trifluoroethylamine hydrochloride giving cis and trans azepane amino 
esters (±)-167b and (±)-169b [regioisomers of (±)-167a and (±)-169a]. In these products, 
the ring nitrogen atom is located at two carbon atom distance from the carbamate group 
(Scheme 35). 
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Scheme 35. Preparation of fluorine-containing cis and trans azepane β-amino esters 
 
 Synthesis of fluorine-containing azabicyclic azepane systems 
In view of the high physiological relevance of N-bridged bicyclic derivatives in 
synthetic and medicinal chemistry, our next aim was the extension of the described 
synthetic technique to the preparation of trifluoromethylated N-bicyclic systems. N-
Heterocyclic bicyclic α- and β-amino acids could be key precursors of medicinally 
important alkaloids such as anatoxin-a, epibatidine, epiboxidine and their analogs (Figure 
9)
76
. 
 
Figure 9. Medicinally important N-bicyclic alkaloids 
 
Taking into consideration the high physiological relevance of N-bridged bicyclic 
motifs, the commercially available diendo norbornene dicarboxylate (±)-173 was 
transformed by dihydroxylation with OsO4 and NMO to diol derivative (±)-174. 
Subsequent oxidative ring opening gave unstable diformyl intermediate (±)-175. Then this 
dialdehyde was transformed without isolation by reductive amination with 
trifluoroethylamine hydrochloride in the presence of NaBH3CN as reducing agent. After 
the purification of the crude product by column chromatography on silica gel (n-
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hexane/EtOAc), the desired N-bicyclic diester (±)-176 was isolated in 29% yield. The 
synthetic approach of N-bicyclic diester is shown in Scheme 36. 
 
Scheme 36. Synthesis of trifluoromethyl-containing N-bicyclic diester (±)-176 
 
N-Heterocyclic β-amino acids have received wide attention due to their 
incorporation into the structure of a peptide
76
. Thus, commercially available diexo 
norbornene β-amino ester (±)-177a was protected by Cbz-Cl with the general procedure 
described above to give (±)-178a. This N-protection was followed by the dihydroxylation 
step to form the desired diol derivative (±)-179a presented in Scheme 37. 
 
Scheme 37. Synthesis of fluorinated N-bicyclic β-amino ester (±)-180a 
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In the next step we have accomplished the oxidative ring cleavage of (±)-179a 
followed by reductive amination with trifluoroethylamine hydrochloride and NaBH3CN in 
the presence of NaHCO3 and AcOH to have N-bicyclic amino ester (±)-180a (Scheme 37). 
The stereocontrolled synthesis of the new N-bridged bicyclic β-amino ester 
containing the trifluoromethyl group could also be accomplished by starting from diendo 
norbornene amino ester (±)-177b. Following the synthetic approach for the diexo isomer, 
N-Cbz-protection of (±)-177b, dihydroxylation, oxidative ring opening and ring 
enlargement via reductive amination with trifluoroethylamine hydrochloride led to 
compound (±)-180b, a stereoisomer of (±)-180a (Scheme 38). 
 
Scheme 38. Synthesis of fluorinated N-bicyclic β-amino ester (±)-180b 
 
Here, we investigated a synthetic procedure for the creation of fluorine-containing 
azepane systems with diverse functionalities. Taking into consideration the availability of 
a wide variety of cycloalkenes and those of functionalized primary amine building blocks, 
this convenient methodology might be further applied towards the synthesis of a series of 
functionalized azepane compounds. 
 
3.4. Synthesis of fluorine-containing 1,2,3,4-tetrahydro-
isoquinoline derivatives 
 
The 1,2,3,4-tetrahydroisoquinoline skeleton (THIQ) has high interest, thanks to 
being an important element of a large number of natural products. Most of them, for 
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example, alkaloids, exhibit a wide range of therapeutic activities. Several drugs, such as 
some antidiuretics, antidepressants, hallucinogens and antihypertensive agents, contain a 
THIQ motif
33,93–98
. Because of these important properties, a large number of synthetic 
approaches towards the creation of an isoquinoline or THIQ core have been described so 
far
95,99–106
. The best-known procedures are the Pictet–Spengler, Bischer–Napieralski, and 
Pomeranz–Fritsch–Bobbit cyclizations, which are widely-applied synthetic techniques to 
create a number of important isoquinoline alkaloids
99
. 
Fluorine-containing tetrahydroisoquinoline or isoquinoline derivatives constitute 
an important segment of fluorinated molecules either as pharmaceuticals or 
agrochemicals
107–109
. The synthesis of fluorinated, fluoroalkylated, and fluoroarylated 
isoquinoline derivatives with precious biological properties continues to be a field of high 
interest in medicinal and organic chemistry. Several methods for the creation of 
monofluorinated, trifluoromethylated or fluoroarylated isoquinolines have been developed 
in recent years
107,108,110–112
. 
In spite of the fact that there are varied strategies to build the isoquinoline skeleton, 
the development of new routes are still highly desirable, because these components could 
be potential pharmaceutical targets. 
Taking into consideration the high biological relevance of THIQ alkaloids and the 
increasing relevance of various organofluorine scaffolds, our goal was to develop a novel 
and efficient procedure for the access of various fluorinated 1,2,3,4- 
tetrahydroisoquinoline derivatives. The developed production path was an unknown way 
in the literature to achieve the desired skeleton. This novel synthetic route was based on 
the expansion of the transformations described above. It involves oxidative ring opening 
and subsequent ring closing with reductive amination starting from indene and some 
substituted indene derivatives. Key steps are C–C double bond oxidative ring cleavage 
through dihydroxylation/NaIO4-mediated oxidation and subsequent cyclization with 
primary amines via reductive amination. 
First, we started with the transformation of unsubstituted 1-H-indene 181. It was 
oxidized with NMO/OsO4 and provided the corresponding vicinal diol derivative (±)-182. 
NaIO4-mediated oxidative ring cleavage of this dihydroxylated compound was carried out 
in THF/H2O to deliver dialdehyde compound 183. This unstable diformyl intermediate 
was further transformed without isolation with various commercially available fluorine-
containing primary amines to give the target compounds in two steps. The reductive 
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amination of 183 with 2-fluoroethylamine, 2,2-difluoroethylamine and 2,2,2-
trifluoroethylamine hydrochlorides, in the presence of NaBH3CN as reducing agent, 
provided the corresponding mono-, di- or trifluoromethyl tetrahydroisoquinoline 
derivatives 184–186 in moderate yields [two steps from (±)-182, Scheme 39]. As the 
results show, the yield of the isoquinoline products decreased on increasing the number of 
fluorine atoms in the final amines. 
 
Scheme 39. Novel synthetic method for the access of 1,2,3,4-tetrahydrisoquinoline 
compounds 
 
The novel synthetic approach was further extended to synthesize other fluorinated 
and polyfluorinated tetrahydroisoquinoline scaffolds. Vicinal diol (±)-182 prepared 
previously subjected to oxidative ring opening followed by the treatment of the resulting 
dialdehyde (183) with various commercially accessible trifluoromethylated or 
polyfluorinated amines furnished the corresponding N-heterocycles (187–190). The novel 
THIQ scaffolds are summarized in Table 1. 
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Diol Fluorinated amine Product 
Yield (%) 
(two steps) 
 
  
(187) 
34 
 
  
(188) 
24 
 
  
(189) 
53 
 
  
(190) 
28 
Table 1. Synthesis of novel fluorinated THIQ frameworks 187–190. 
 
In continuation, the synthetic route presented above was further extended by using 
1H-indene derivatives with substituents attached to the benzene ring of indene. 7-Bromo-
1H-indene 191 was selected as a model compound. cis-Dihydroxylation conducted in the 
presence of OsO4 and N-methylmorpholine N-oxide (NMO) gave the corresponding 
vicinal diol (±)-192. Oxidative ring opening with NaIO4 in THF/H2O at room temperature, 
analogously to the unsubstituted derivative, gave unstable diformyl-substituted 
intermediate 193 in 1 h. Further reaction―reductive ring expansion―without isolation 
was executed with both 2,2,2-trifluoroethylamine and 2,2-difluoroethylamine under 
reductive conditions in the presence of NaBH3CN and NaHCO3 in EtOH at room 
temperature. Ring formation occurred by double-reductive amination and provided the 
corresponding trifluorinated or difluorinated tetrahydroisoquinoline derivatives 194 and 
195 (Scheme 40).  
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Scheme 40. Preparation of a novel N-heterocyclic frameworks from 7-bromo-1H-indene 
via diformyl intermediate 193 
 
The protocol described above was further extended to the synthesis of the other 
selected model compound, 2-methyl-1H-indene 196. In this case, the five-membered ring 
of the indene was substituted. The first step of the generalized synthetic path was the 
oxidation of the olefinic bond to achieve cis-diol (±)-197. Subsequent ring cleavage with 
NaIO4 led to dicarbonyl derivative 198, which was immediately used after workup in the 
reductive amination step. Isoquinoline product (±)-199 was furnished with 
trifluoroethyamine hydrochloride generating a chiral center. The crude product was 
purified by means of column chromatography on silica gel (n-hexane/EtOAc) to provide a 
moderate product yield of 33% [two steps from (±)-197, Scheme 41]. 
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Scheme 41. Preparation of a novel N-heterocyclic framework from 2-methyl-1H-indene 
via dicarbonyl intermediate 198 
 
Finally, our last goal was to apply this 1,2,3,4-tetrahydroisoquinoline ring-forming 
synthetic procedure for the access of various non-fluorinated substances, to prove general 
applicability (Scheme 42). 
 
Scheme 42. Generalization of the developed method 
 
The generalization and extension of the developed pathway was demonstrated by 
utilizing three different primary amines: ethylamine (as the nonfluorinated counterpart of 
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the mono-, di- or trifluoroethylamines used earlier), butylamine (as an alkylamine) and 
benzylamine (as an arylalkylamine). These amines upon reacting with diformyl 
intermediate 183 [derived from diol (±)-182] produced the corresponding N-substituted 
tetrahydroisoquinoline products 200–202 through cyclization in moderate yields. After the 
purification of the residue by column chromatography on silica gel (n-hexane/EtOAc), the 
highest yield of 69% was attained with benzylamine [two steps from (±)-182] (Scheme 
42). 
 This novel synthetic route could offer an alternative, easy and efficient procedure 
for the access of THIQ frameworks. Apart from this insight into the presented synthetic 
approach, other extensions of this method (applying amines with diverse substitution 
patterns or various indene motifs) could open new ways towards the accesses of various 
substituted 1,2,3,4-tetrahydroisoquinoline derivatives. 
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4. SUMMARY 
1. A simple strategy was developed for the introduction of a fluorine atom into the 
structure of varied molecules via dihydroxylation of the olefinic bond, followed by 
NaIO4-mediated oxidative ring cleavage of the diol intermediate and ring expansion 
under reductive amination, resulting in novel fluorine-containing N-heterocycles. 
2. The required starting materials were synthesized by using simple, known literature 
methods. 
2.1.  Five- and six-membered substituted cycloalkenes 122, 124 and (±)-125 were 
prepared from commercially available cyclopent-3-enecarboxylic acid 121 and 
cyclohex-3-enecarboxylic acid (±)-123 via the Curtius reaction and esterification 
(Scheme 23) 
2.2. N-Protected β-aminocyclopentene carboxylates (±)-128a,b and β-aminocyclohexene 
carboxylates (±)-131a,b were prepared and used as starting materials, with two 
different protecting groups (Cbz and COPh) from readily available unsaturated 
bicyclic β-lactams (±)-127 and (±)-130a,b (Scheme 24) 
2.3. With the epimerization at C-1, the corresponding trans β-amino carboxylate isomers 
(±)-132a,b and (±)-133a,b were synthetized (Scheme 25)  
3. Synthesis of fluorine-containing piperidine derivatives 
3.1. The synthetic concept to fluorine-containing 141, 142, 143 and 146 molecules 
included the use of a commercially accessible reagent, a fluorine-containing amine, 
and was based on the oxidative ring cleavage of the unsaturated five-membered 
starting materials described above, followed by ring closure by reductive amination 
and ring expansion of diformyl intermediates (Scheme 26, Scheme 27, Scheme 28) 
3.2. Unsaturated β-amino ester (±)-128a,b and (±)-132-a,b were transformed into β-
amino esters with piperidine skeleton [(±)-149a,b, (±)-152a,b, (±)-153 and (±)-154]. 
The configuration of the chiral centers in (±)-149a,b, (±)-152a,b, (±)-153 and (±)-
154 are predetermined by the structure of the starting materials since the 
stereocenters of amino esters at C-1 and C-2 were not affected during the ring 
expansion procedure. Consequently, the cis amino ester afforded the corresponding 
piperidine derivative with the carboxylate and carbamate/amide functions in a cis 
relative arrangement. In the same way, the trans amino ester afforded the 
corresponding piperidine derivative with trans relative arrangement of the 
substituents (Scheme 29, Scheme 30) 
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4. Synthesis of fluorine-containing azepane frameworks. 
4.1. Starting materials ethyl cyclohex-3-enecarboxylate (±)-155 (a commercial product) 
and cyclohexeneamine (±)-125 synthesized by the Curtius reaction were further used 
for the ring-opening step, and the corresponding open-chain dialdehydes were next 
transformed to the desired substituted azepane derivatives (±)-158 and (±)-161 
containing the trifluoromethyl group (Scheme 31, Scheme 32) 
4.2. Disubstituted trifluoromethylated azepane derivative 165 was synthesized from 
commercially available cyclohexene cis-diester 162 (Scheme 33) 
4.3. The above synthetic approach was applied for the stereocontrolled synthesis of 
trifluoromethylated azepane β-aminocarboxylate regio- and stereoisomers. Amino 
esters cis-(±)-167a and trans-(±)-169a with an azepane ring were prepared via 
oxidative ring cleavage and stereocontrolled ring enlargement through reductive 
amination with 2,2,2-trifluoroethylamine hydrochloride. In the trifluoromethylated 
azepane products there is a three-carbon-atom distance between the carbamate group 
and the ring nitrogen atom. The preparation of regioisomers (±)-167b and (±)-169b 
of the trifluoromethylated azepane derivatives described above were performed. In 
these products, the ring nitrogen atom is located at a two-carbon-atom distance from 
the carbamate group (Scheme 34, Scheme 35) 
4.4.  Trifluormethyl-containing N-bicyclic diester (±)-176, diexo and diendo β-amino 
ester frameworks (±)-180a and (±)-180b were prepared with the developed reaction 
path (Scheme 36, Scheme 37, Scheme 38) 
5. Synthesis of novel 1,2,3,4-tetrahydroisoquinoline scaffolds  
5.1. Indene 181 and substituted indene derivatives 191 and 196 as starting materials 
afforded novel fluorine-containing tetrahydroisoquinoline compounds 184–190, 194, 
195 and (±)-199 (Scheme 39, Scheme 40, Scheme 41, Table 1) 
5.2. The generalization of the developed pathway was demonstrated by utilizing three 
different non-fluorinated primary amines. The corresponding N-substituted 
tetrahydroisoquinoline products 200–202 were isolated in moderate yields (Scheme 
42) 
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